文献速递皮肤肿瘤毛发、甲与色素性疾病

多发性甲乳头状瘤与BAP1肿瘤易感综合征

Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome.
PubMed 文献 · JAMA Dermatol · 2024-01-01

这项前瞻性队列研究在2023年10月至2024年3月连续纳入47名已知携带致病性BAP1胚系变异的个体,评估指甲异常。41人(87.2%)存在指甲异常,39人(83.0%)临床符合甲乳头状瘤,提示多发性甲乳头状瘤可能是BAP1肿瘤易感综合征的皮肤线索。

要点

  • 成人BAP1致病性胚系变异携带者中甲乳头状瘤常见,检出率达83.0%。
  • 有甲受累者几乎均为多指(趾)受累(38/39,97.4%)。
  • 多发性甲乳头状瘤罕见,或有助于识别高危家系成员及BAP1相关癌症患者。

核心结论

  • BAP1肿瘤易感综合征与成人携带者中高比例的甲乳头状瘤样指甲异常相关。
  • 多发性甲乳头状瘤在普通人群中不常见,可能是BAP1致病性胚系变异的独特线索。

研究设计与样本

  • 前瞻性队列研究,单中心,于美国国立卫生研究院临床中心开展。
  • 2023年10月10日至2024年3月15日连续纳入已知携带致病性BAP1胚系变异的个体47名(30名女性,63.8%;平均年龄46.4岁,SD 15.1;年龄范围13至72岁;来自35个家庭)。
  • 评估包括指甲异常病史及相关症状、体格检查、医学摄影及指甲活检组织病理学。

主要发现

  • 41名患者(87.2%)检出指甲异常,包括白甲、裂片形出血、甲纵裂和远端甲肥厚。
  • 39名患者(83.0%)临床发现符合甲乳头状瘤,其中40名30岁及以上个体中35名(87.5%)符合。
  • 5名患者行甲床活检,结果与甲乳头状瘤一致。
  • 有甲受累的39名患者中38名(97.4%)存在多指(趾)甲乳头状瘤受累。

临床怎么用

  • 对BAP1致病性胚系变异携带者及其高危家系成员应仔细检查指甲,关注多发性甲乳头状瘤。
  • 发现多发性甲乳头状瘤时,可考虑提示BAP1肿瘤易感综合征并转诊遗传咨询。
  • 指甲异常评估可结合皮肤镜检查与必要时的甲床活检以辅助识别。

局限性

  • 单中心研究,样本量47名,来自35个家庭。
  • 研究仅纳入已知BAP1致病性胚系变异携带者,缺乏普通人群或其他皮肤病人群的对照。
  • 仅5名患者行甲床活检,组织病理学验证样本有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: BRCA1-associated protein (BAP1) tumor predisposition syndrome (TPDS) is a cancer genodermatosis associated with high risk of uveal and cutaneous melanoma, basal cell carcinoma, and multiple internal malignant neoplasms, including mesothelioma and renal cell carcinoma. Early detection of the syndrome is important for cancer surveillance and genetic counseling of family members who are at risk. OBJECTIVE: To determine the prevalence of nail abnormalities in individuals with pathogenic germline variants in BAP1. DESIGN, SETTING, AND PARTICIPANTS: In this prospective cohort study, individuals who were known carriers of pathogenic BAP1 germline variants were consecutively enrolled between October 10, 2023, and March 15, 2024. Dermatologic evaluation for nail abnormalities was performed, including a history of nail abnormalities and associated symptoms, physical examination, medical photography, and nail biopsy for histopathology. This was a single-center study conducted at the National Institutes of Health Clinical Center. MAIN OUTCOMES AND MEASURES: Primary outcomes were the prevalence and spectrum of nail changes and histopathologic characterization. RESULTS: Among 47 participants (30 female [63.8%]; mean [SD] age, 46.4 [15.1] years) ranging in age from 13 to 72 years from 35 families, nail abnormalities were detected in 41 patients (87.2%) and included leukonychia, splinter hemorrhage, onychoschizia, and distal nail hyperkeratosis. Clinical findings consistent with onychopapilloma were detected in 39 patients (83.0%), including 35 of 40 individuals aged 30 years or older (87.5%). Nail bed biopsy was performed in 5 patients and was consistent with onychopapilloma. Polydactylous involvement with onychopapillomas was detected in nearly all patients who had nail involvement (38 of 39 patients [97.4%]). CONCLUSIONS AND RELEVANCE: This study found that BAP1 TPDS was associated with a high rate of nail abnormalities consistent with onychopapillomas in adult carriers of the disease. Findings suggest that this novel cutaneous sign may facilitate detection of the syndrome in family members who are at risk and patients with cancers associated with BAP1 given that multiple onychopapillomas are uncommon in the general population and may be a distinct clue to the presence of a pathogenic germline variant in the BAP1 gene.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Lebensohn A, Ghafoor A, Bloomquist L, et al. Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome. JAMA Dermatol. 2024. PMID: 38759225. doi:10.1001/jamadermatol.2024.1804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。